296 results on '"Courvoisier, D"'
Search Results
2. OP0092 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: FINDINGS FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)
3. POS0832 IMMUNOSUPPRESSION VERSUS COMBINATION OF IMMUNOSUPPRESSION AND ORAL GLUCOCORTICOIDS FOR SKIN FIBROSIS IN EARLY DIFFUSE SYSTEMIC SCLEROSIS PATIENTS. A TARGET TRIAL EMULATION STUDY FROM THE EUSTAR DATABASE
4. AB1469 PROSPECTIVE REGISTRATION IN RHEUMATOLOGY RANDOMIZED CONTROLLED TRIALS: WHERE WE ARE, WHY, AND HOW WE COULD GET BETTER
5. POS0570 DEVELOPMENT AND IMPLEMENTATION OF GOUT QUALITY CRITERIA IN AN ELECTRONIC HEALTH RECORD-BASED GOUT REGISTER: A FEASIBILITY STUDY
6. AB0117 FACTORS ASSOCIATED WITH POOR GOUT OUTCOME IN A REGIONAL HOSPITAL REGISTER
7. AB1466 PERSISTING GENDER DISPARITIES IN RHEUMATOLOGY RESEARCH: AN ANALYSIS OF AUTHORSHIP TRENDS IN RANDOMISED CONTROLLED TRIALS
8. Prevalence and risk factors for seclusion and restraint at Geneva’s adult psychiatric hospital in 2017
9. Towards standardized patient reported physical function outcome reporting : linking ten commonly used questionnaires to a common metric
10. Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric
11. AB1602 CROSS COUNTRY DIFFERENCES IN B/TSDMARD PRESCRIPTION BEHAVIOR: ASSOCIATIONS BETWEEN SOCIOECONOMICS, REAL WORLD B/TSDMARD USE AND DISEASE OUTCOMES
12. AB1600 TIME TO PUBLICATION AND TIME-LAG PUBLICATION BIAS FOR RANDOMIZED TRIALS ON CONNECTIVE TISSUE DISEASES
13. POS0523 FEASIBILITY STUDY OF AN ELECTRONIC HEALTH RECORD-BASED GOUT REGISTRY
14. OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)
15. Validity of dynamical analysis to characterize heart rate and oxygen consumption during effort tests
16. Identification de facteurs de risque et développement d’un score prédictif de progression d’un lupus discoïde vers un lupus systémique sévère : étude de cohorte rétrospective de 164 patients
17. The protective effect of reserves on mental health: a cohort study among undocumented migrants
18. How much does the Dallas Pain Questionnaire score have to improve to indicate that patients with chronic low back pain feel better or well?
19. Core Outcome Measure Index for low back patients: do we miss anxiety and depression?
20. Comparing Residential Programmes for Adults with Autism Spectrum Disorders and Intellectual Disability: Outcomes of Challenging Behaviour and Quality of Life
21. OP0266 TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS AS AN OVERALL MEASURE OF TOLERANCE AND SAFETY OF JAK-INHIBITORS: AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-pot” STUDY).
22. POS0874 GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE.
23. POS1179 SYSTEMATIC LITERATURE REVIEW ON THE SCREENING AND PROPHYLAXIS OF CHRONIC AND OPPORTUNISTIC INFECTIONS
24. POS1420 DOUBLY ROBUST ESTIMATOR FOR AVERAGE TREATMENT EFFECT AS SENSITIVITY ANALYSIS FOR COMPARATIVE EFFECTIVENESS RESEARCH. AN EXAMPLE COMPARING DRUG MAINTENANCE BETWEEN BARICITINIB AND ALTERNATIVE BIOLOGIC DMARDS.
25. POS0435 IMPACT OF COMBINATION THERAPY WITH csDMARDs ON THE EFFECTIVENESS OF BIOLOGIC OR TARGETED SYNTHETIC DMARDs IN A REAL-LIFE SETTING: RESULTS FROM THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM-RA)
26. Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
27. HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)
28. POS0668 REAL WORLD EFFECTIVENESS OF BARICITINIB IN THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM-RA)
29. POS0093 HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)
30. OP0105 FEASIBILITY AND USEFULNESS OF MAPPING BIOLOGIC REGISTRIES TO A COMMON DATA MODEL: ILLUSTRATION USING COMORBIDITIES
31. Comparative effectiveness of JAK-inhibitors, TNF-inhibitors, abatacept and IL-6 inhibitors in an international collaboration of registers of rheumatoid arthritis patients (the 'JAK-POT' study)
32. Hyperéosinophilie au diagnostic de la granulomatose avec polyangéite (GPA) : prévalence, présentation et pronostic
33. Granulomatose avec polyangéite : analyse des 795 patients de la base de données du groupe français d’étude des vascularites
34. The complex relationship between effort and heart rate: a hint from dynamic analysis
35. Comparing residential programmes for adults with autism spectrum disorders and intellectual disability: outcomes of challenging behaviour and quality of life
36. Reply from the authors
37. Clinical factors associated with the non-utilization of an anaesthesia incident reporting system
38. SPINAL AND SUPRASPINAL ANTINOCICEPTIVE AND ANALGESIC EFFECTS OF MILNACIPRAN IN FIBROMYALGIA: P194
39. Changes of heart rate variability during exercise
40. OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)
41. OP0285 TOWARDS IMPLEMENTING THE OMOP CDM ACROSS FIVE EUROPEAN BIOLOGIC REGISTRIES
42. THU0203 REAL WORLD EFFECTIVENESS OF BARICITINIB IN THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM-RA)
43. OP0198 A SYSTEMATIC REVIEW TO INFORM THE EULAR POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY
44. OP0199 POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY
45. The complex relationship between effort and heart rate: a hint from dynamical analysis
46. Validity of dynamical analysis to characterize heart rate and oxygen consumption during effort tests
47. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
48. An investigation into intermittency
49. Improved measurements of electroweak parameters fromZ decays into fermion pairs
50. Measurement of electroweak parameters fromZ decays into fermion pairs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.